SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-035667
Filing Date
2009-02-24
Accepted
2009-02-24 08:20:00
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1482263
2 SEVERANCE AGREEMENT DATED JANUARY 1, 2001 dex10162.htm EX-10.162 37761
3 DEFERRED COMPENSATION PLAN FOR NON-EMPLOYEE DIRECTORS dex10264.htm EX-10.264 92898
4 DEFERRED COMPENSATION PLAN FOR EXECUTIVES dex10265.htm EX-10.265 100322
5 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 30915
6 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1929
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9318
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9316
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3328
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3326
  Complete submission text file 0001193125-09-035667.txt   1772807
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 09629525
SIC: 8731 Services-Commercial Physical & Biological Research